These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6249510)

  • 21. Status of immunity against poliomyelitis in the acute flaccid paralysis (AFP) cases in Romania between 2009-2012.
    Băicuş A
    Roum Arch Microbiol Immunol; 2014; 73(1-2):56-60. PubMed ID: 25518572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poliomyelitis in developing countries: lower limb paralysis and injections.
    Wyatt HV
    Trans R Soc Trop Med Hyg; 1989; 83(4):545-9. PubMed ID: 2617611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of paralytic poliomyelitis in the United States. 1966 and 1967 cases, and 1965-1967 cases associated with oral poliovirus vaccine.
    Hopkins CC; Dismukes WE; Glick TH; Warren RJ
    JAMA; 1969 Oct; 210(4):694-700. PubMed ID: 4309925
    [No Abstract]   [Full Text] [Related]  

  • 24. Massive outbreak of poliomyelitis caused by type-3 wild poliovirus in Angola in 1999.
    Valente F; Otten M; Balbina F; Van de Weerdt R; Chezzi C; Eriki P; Van-Dúnnen J; Bele JM
    Bull World Health Organ; 2000; 78(3):339-46. PubMed ID: 10812730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poliomyelitis outbreak--Albania, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Sep; 45(38):819-20. PubMed ID: 8927000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence for prolonged excretion of polioviruses in persons with residual paralytic poliomyelitis in Ethiopia, Pakistan and Guatemala.
    Khan AJ; Gebreselassie H; Asturias EJ; Agboatwalla M; Teklehaimanot R; Luby SP; Beyene B; Chezzi C; Asghar H; Moatter T; Torres OR; Kew O; Winkelstein J; Halsey NA
    Biologicals; 2006 Jun; 34(2):113-6. PubMed ID: 16682222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The paralytic poliomyelitis epidemic of 1978 in Jordan: epidemiological implications.
    Khuri-Bulos N; Melnick JL; Hatch MH; Dawod ST
    Bull World Health Organ; 1984; 62(1):83-8. PubMed ID: 6609022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell mediated immunity to polio antigens in the early stage of acute poliomyelitis.
    Livni R; Lasch EE; Englander T; El Massri M; Danon YL
    Allergol Immunopathol (Madr); 1984; 12(2):119-22. PubMed ID: 6087647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
    Wyatt HV
    Dev Biol Stand; 1986; 65():123-6. PubMed ID: 3549394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.
    Orstavik I; Flugsrud LB; Lahelle O
    Bull World Health Organ; 1971; 45(6):733-9. PubMed ID: 4336552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
    Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
    Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poliomyelitis survey in Middle-East countries.
    Brigaud M; Aymard M; Thouvenot D; Chomel JJ; Mahmood RA; Mathew PP; Jafar AK
    Dev Biol Stand; 1978; 41():149-58. PubMed ID: 223907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
    Aylward RB; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):40-6. PubMed ID: 15106299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of injury-provoked poliomyelitis.
    Gromeier M; Wimmer E
    J Virol; 1998 Jun; 72(6):5056-60. PubMed ID: 9573275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.
    Nkowane BM; Wassilak SG; Orenstein WA; Bart KJ; Schonberger LB; Hinman AR; Kew OM
    JAMA; 1987 Mar; 257(10):1335-40. PubMed ID: 3029445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prevalence survey of lower limb motor disorders in school-age children in Niger and an estimation of poliomyelitis incidence.
    Thuriaux MC
    Trop Geogr Med; 1982 Jun; 34(2):163-8. PubMed ID: 6981872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of paralytic poliomyelitis in the Chechen Republic in 1995.
    Ivanova OE; Eremeeva TP; Lipskaya GY; Cherkasova EA; Gavrilin EV; Drozdov SG
    Dev Biol (Basel); 2001; 105():231-7. PubMed ID: 11763333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Poliomyelitis in New Caledonia: epidemiological data, post-vaccinal seroconversion, prophylactic strategy].
    Louis JP; Panon G; Le Gonidec G
    Med Trop (Mars); 1985; 45(3):223-33. PubMed ID: 2999557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.